Literature DB >> 24312876

Development and Validation of UV-Visible Spectrophotometric Method for Simultaneous Determination of Eperisone and Paracetamol in Solid Dosage Form.

Shantaram Gajanan Khanage1, Popat Baban Mohite, Sandeep Jadhav.   

Abstract

PURPOSE: Eperisone Hydrochloride (EPE) is a potent new generation antispasmodic drug which is used in the treatment of moderate to severe pain in combination with Paracetamol (PAR). Both drugs are available in tablet dosage form in combination with a dose of 50 mg for EPE and 325 mg PAR respectively.
METHODS: The method is based upon Q-absorption ratio method for the simultaneous determination of the EPE and PAR. Absorption ratio method is used for the ratio of the absorption at two selected wavelength one of which is the iso-absorptive point and other being the λmax of one of the two components. EPE and PAR shows their iso-absorptive point at 260 nm in methanol, the second wavelength used is 249 nm which is the λmax of PAR in methanol.
RESULTS: The linearity was obtained in the concentration range of 5-25 μg/mL for EPE and 2-10 μg/mL for PAR. The proposed method was effectively applied to tablet dosage form for estimation of both drugs. The accuracy and reproducibility results are close to 100% with 2% RSD. RESULTS of the analysis were validated statistically and found to be satisfactory. The results of proposed method have been validated as per ICH guidelines.
CONCLUSION: A simple, precise and economical spectrophotometric method has been developed for the estimation of EPE and PAR in pharmaceutical formulation.

Entities:  

Keywords:  Absorption ratio method; Eperisone Hydrochloride; ICH; Iso-absorptive point; Paracetamol; Spectrophotometric method

Year:  2013        PMID: 24312876      PMCID: PMC3848213          DOI: 10.5681/apb.2013.073

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  6 in total

1.  A rapid quantitative assay of intact paracetamol tablets by reflectance near-infrared spectroscopy.

Authors:  A D Trafford; R D Jee; A C Moffat; P Graham
Journal:  Analyst       Date:  1999-02       Impact factor: 4.616

2.  The use of HPLC/MS, GC/MS, NMR, UV and IR to identify a degradation product of eperisone hydrochloride in the tablets.

Authors:  Li Ding; Xiaoyun Wang; Zheng Yang; Yan Chen
Journal:  J Pharm Biomed Anal       Date:  2007-10-02       Impact factor: 3.935

3.  Rapid and sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the determination of eperisone in human plasma: method and clinical applications.

Authors:  Li Ding; Xin Wei; Shengqiang Zhang; Jianpin Sheng; Yindi Zhang
Journal:  J Chromatogr Sci       Date:  2004 May-Jun       Impact factor: 1.618

4.  Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.

Authors:  P Cabitza; P Randelli
Journal:  Eur Rev Med Pharmacol Sci       Date:  2008 Jul-Aug       Impact factor: 3.507

5.  Development of the second-order derivative UV spectrophotometric method for direct determination of paracetamol in urine intended for biopharmaceutical characterisation of drug products.

Authors:  Jelena Parojcić; Katarina Karljiković-Rajić; Zorica Durić; Milica Jovanović; Svetlana Ibrić
Journal:  Biopharm Drug Dispos       Date:  2003-10       Impact factor: 1.627

6.  Simultaneous spectrophotometric determination of paracetamol, phenylephrine and chlropheniramine in pharmaceuticals using chemometric approaches.

Authors:  M R Khoshayand; H Abdollahi; A Ghaffari; M Shariatpanahi; H Farzanegan
Journal:  Daru       Date:  2010       Impact factor: 3.117

  6 in total
  1 in total

1.  Simultaneous Determination of Acetaminophen and Synthetic Color(s) by Derivative Spectroscopy in Syrup Formulations and Validation by HPLC: Exposure Risk of Colors to Children.

Authors:  Shanya Das Rastogi; Sumita Dixit; Anurag Tripathi; Mukul Das
Journal:  AAPS PharmSciTech       Date:  2014-11-06       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.